Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine

NCT05493917 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT05493917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05493917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine
Lead sponsor
Huashan Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 3, 2021
Completion date
December 31, 2022
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, vaccine reaction